Skip to main content
. 2021 Sep 15;11:18394. doi: 10.1038/s41598-021-97549-0

Figure 9.

Figure 9

Insulin tolerance tests (ITTs) (A, B) and oral glucose tolerance tests (OGTTs) (C, D) in mice from the Lepr knockdown study. In (A), n = 18 for Cre+Leprflox/flox, n = 20 for CreLeprflox/flox, n = 12 for Cre+Lepr+/+, and n = 13 for CreLepr+/+. In (B), n = 20 for Cre+Leprflox/flox, n = 17 for CreLeprflox/flox, n = 9 for Cre+Lepr+/+, and n = 8 for CreLepr+/+. In (C), n = 15 for Cre+Leprflox/flox, n = 18 for CreLeprflox/flox, n = 11 for Cre+Lepr+/+, and n = 12 for CreLepr+/+. In (D), n = 20 for Cre+Leprflox/flox, n = 16 for CreLeprflox/flox, n = 9 for Cre+Lepr+/+, and n = 8 for CreLepr+/+. Performed repeated measures two-way ANOVA with post-hoc analysis. p < 0.05, CreLeprflox/flox vs. Cre+Lepr+/+; &p < 0.05, Cre+Leprflox/flox vs. Cre+Lepr+/+; **p < 0.05, Cre+Leprflox/flox vs. CreLepr+/+. Main effect of time (p < 0.05) in (AD).